Use of Direct Oral Anticoagulants in Patients With Antiphospholipid Syndrome: A Systematic Review and Comparison of the International Guidelines

Antiphospholipid antibody syndrome (APS) requires long-term anticoagulation to prevent recurrent thrombosis. Direct oral anticoagulants (DOACs) have been increasingly used in APS patients, but contradictory guidelines recommendations on their use do exist. We performed a systematic review of literat...

Descripción completa

Detalles Bibliográficos
Autores principales: Pastori, Daniele, Menichelli, Danilo, Cammisotto, Vittoria, Pignatelli, Pasquale
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8368436/
https://www.ncbi.nlm.nih.gov/pubmed/34414220
http://dx.doi.org/10.3389/fcvm.2021.715878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8368436/
https://www.ncbi.nlm.nih.gov/pubmed/34414220
http://dx.doi.org/10.3389/fcvm.2021.715878

Ejemplares similares